Abstract
In the last years, the incidence of Candida infections in liver transplant recipients has increased with still higher morbidity and mortality. Anidulafungin, a new echinocandin that does not interfere with cytochrome p450, shows no need for dosage adjustment based upon renal or hepatic function or weight.
Lingua originale | English |
---|---|
pagine (da-a) | 1982-1985 |
Numero di pagine | 4 |
Rivista | Transplantation Proceedings |
Volume | 44 |
DOI | |
Stato di pubblicazione | Pubblicato - 2012 |
Keywords
- Adult
- Aged
- Candidiasis
- Female
- Humans
- Liver Transplantation
- Male
- Middle Aged
- Prospective Studies